CollPlant Biotechnologies (CLGN) Total Current Liabilities (2017 - 2025)

CollPlant Biotechnologies' Total Current Liabilities history runs 9 years deep, the most recent figure standing at $2.7 million for Q4 2025.

• Quarterly Total Current Liabilities fell 10.03% year-over-year to $2.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.7 million (down 10.03% YoY) and the FY2025 annual result came in at $2.7 million, down 10.03% from the prior year.
• Total Current Liabilities was $2.7 million for Q4 2025 at CollPlant Biotechnologies, up from $2.6 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $3.4 million in Q1 2024 and bottomed at $2.3 million in Q3 2022.
• A 5-year average of $2.9 million and a median of $2.9 million in 2023 frame the typical range for Total Current Liabilities.
• Annual changes were most pronounced in 2021 — Total Current Liabilities surged 34.79% — and 2022, when it declined 22.65%.
• CollPlant Biotechnologies' Total Current Liabilities stood at $3.0 million in 2021, then rose by 3.02% to $3.1 million in 2022, then advanced by 4.7% to $3.3 million in 2023, then declined by 8.64% to $3.0 million in 2024, then decreased by 10.03% to $2.7 million in 2025.
• Business Quant data shows CLGN's Total Current Liabilities at $2.7 million in Q4 2025, $2.6 million in Q3 2025, and $2.7 million in Q2 2025.